{"DataElement":{"publicId":"3298602","version":"1","preferredName":"Leukodystrophy Classification Type","preferredDefinition":"A description of the leukodystrophy classification.","longName":"3298599v1.0:3298601v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3298599","version":"1","preferredName":"Leukodystrophy Classification","preferredDefinition":"A group of rare genetic neurodegenerative disorders that affect infants and children. These disorders are characterized by metabolic abnormalities in the development of the myelin sheaths in the white matter. Clinical signs and symptoms include developmental delays, mental retardation, dementia, seizures, loss of motor skills, and muscle weakness. Representative examples include metachromatic leukodystrophy, Krabbe disease, Canavan disease, and Alexander disease._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"3298597v1.0:2321361v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"3298597","version":"1","preferredName":"Leukodystrophy","preferredDefinition":"A group of rare genetic neurodegenerative disorders that affect infants and children. These disorders are characterized by metabolic abnormalities in the development of the myelin sheaths in the white matter. Clinical signs and symptoms include developmental delays, mental retardation, dementia, seizures, loss of motor skills, and muscle weakness. Representative examples include metachromatic leukodystrophy, Krabbe disease, Canavan disease, and Alexander disease.","longName":"C61253","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukodystrophy","conceptCode":"C61253","definition":"A group of rare genetic neurodegenerative disorders that affect infants and children. These disorders are characterized by metabolic abnormalities in the development of the myelin sheaths in the white matter. Clinical signs and symptoms include developmental delays, mental retardation, dementia, seizures, loss of motor skills, and muscle weakness. Representative examples include metachromatic leukodystrophy, Krabbe disease, Canavan disease, and Alexander disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B05C6036-0A9D-024C-E040-BB89AD43392F","latestVersionIndicator":"Yes","beginDate":"2011-10-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-10-28","modifiedBy":"ONEDATA","dateModified":"2011-10-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2321361","version":"1","preferredName":"Classification","preferredDefinition":"Classification; the grouping of things into classes or categories.","longName":"C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCF89106-20AF-2D93-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-29","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-29","modifiedBy":"ONEDATA","dateModified":"2005-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B05C6036-0AAB-024C-E040-BB89AD43392F","latestVersionIndicator":"Yes","beginDate":"2011-10-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-10-28","modifiedBy":"KUMMEROA","dateModified":"2021-06-25","changeDescription":". 2021-6-25 ak Released per Janet review.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3298601","version":"1","preferredName":"Leukodystrophy Type","preferredDefinition":"A group of rare genetic neurodegenerative disorders that affect infants and children. These disorders are characterized by metabolic abnormalities in the development of the myelin sheaths in the white matter. Clinical signs and symptoms include developmental delays, mental retardation, dementia, seizures, loss of motor skills, and muscle weakness. Representative examples include metachromatic leukodystrophy, Krabbe disease, Canavan disease, and Alexander disease._Type; a subdivision of a particular kind of thing.","longName":"3298601v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Metachromatic leukodystrophy","valueDescription":"Metachromatic Leukodystrophy","ValueMeaning":{"publicId":"2593450","version":"1","preferredName":"Metachromatic Leukodystrophy","longName":"2593450","preferredDefinition":"An autosomal recessive inherited disorder characterized by abnormalities in the development of the myelin sheaths. It is caused by a deficiency of the enzyme arylsulfatase A. There are three forms of this disease: late infantile, juvenile, and adult. In the late infantile form symptoms include muscle weakness and rigidity, gait disturbances, developmental delays, and seizures. In the juvenile form symptoms include gait disturbances, mental deterioration and seizures. The adult form is characterized by psychotic symptoms and dementia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metachromatic Leukodystrophy","conceptCode":"C61251","definition":"An autosomal recessive inherited disorder characterized by abnormalities in the development of the myelin sheaths. It is caused by a deficiency of the enzyme arylsulfatase A. There are three forms of this disease: late infantile, juvenile, and adult. In the late infantile form symptoms include muscle weakness and rigidity, gait disturbances, developmental delays, and seizures. In the juvenile form symptoms include gait disturbances, mental deterioration and seizures. The adult form is characterized by psychotic symptoms and dementia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28BBABB0-0B0C-4B1B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B05C6036-0B10-024C-E040-BB89AD43392F","beginDate":"2011-10-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-10-28","modifiedBy":"ONEDATA","dateModified":"2011-10-28","deletedIndicator":"No"},{"value":"Adrenoleukodystrophy","valueDescription":"Adrenoleukodystrophy","ValueMeaning":{"publicId":"2593452","version":"1","preferredName":"Adrenoleukodystrophy","longName":"2593452","preferredDefinition":"A rare metabolic disorder characterized by damage of the myelin sheaths in the nervous system and degeneration of the adrenal glands. It leads to progressive neurologic disorders, adrenal insufficiency and death.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenoleukodystrophy","conceptCode":"C61252","definition":"A rare metabolic disorder characterized by damage of the myelin sheaths in the nervous system and degeneration of the adrenal glands. It leads to progressive neurologic disorders, adrenal insufficiency and death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28BBAC12-A50B-4B21-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B53C72F8-3523-5471-E040-BB89AD43433C","beginDate":"2011-10-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-29","modifiedBy":"ONEDATA","dateModified":"2011-12-29","deletedIndicator":"No"},{"value":"Krabbe Disease (globoid cell leukodystrophy)","valueDescription":"Krabbe Disease","ValueMeaning":{"publicId":"2593454","version":"1","preferredName":"Krabbe Disease","longName":"2593454","preferredDefinition":"A rare inherited neurodegenerative disorder that belongs to the group of leukodystrophies. It is characterized by myelin destruction, gliosis in the brain, and the presence of multinucleated globoid cells. Signs and symptoms include irritability, mental and motor developmental disturbances, muscle weakness, seizures, blindness, and deafness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Krabbe Disease","conceptCode":"C61254","definition":"A rare inherited neurodegenerative disorder that belongs to the group of leukodystrophies. It is characterized by myelin destruction, gliosis in the brain, and the presence of multinucleated globoid cells. Signs and symptoms include irritability, mental and motor developmental disturbances, muscle weakness, seizures, blindness, and deafness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28BBAC79-C5A9-4B39-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C46CAD4B-F48A-1809-E053-4EBD850AB676","beginDate":"2011-10-28","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-06-10","modifiedBy":"ONEDATA","dateModified":"2021-06-10","deletedIndicator":"No"},{"value":"Hereditary diffuse leukoencephalopathy with spheroids (HDLS)","valueDescription":"Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia","ValueMeaning":{"publicId":"7685355","version":"1","preferredName":"Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia","longName":"7685355","preferredDefinition":"A rapidly progressive neurodegenerative disorder, caused by mutations in the colony-stimulating factor 1 receptor (CSF1R) gene, that presents in adulthood with a variety of neuropsychiatric and motor disturbances. Hallmark features include diffuse myelin loss and axonal destruction, neuroaxonal spheroids, and pigmented macrophages and other glia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia","conceptCode":"C153289","definition":"A rapidly progressive neurodegenerative disorder, caused by mutations in the colony-stimulating factor 1 receptor (CSF1R) gene, that presents in adulthood with a variety of neuropsychiatric and motor disturbances. Hallmark features include diffuse myelin loss and axonal destruction, neuroaxonal spheroids, and pigmented macrophages and other glia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C46F9B82-5EE8-14D5-E053-4EBD850A99AD","latestVersionIndicator":"Yes","beginDate":"2021-06-10","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-06-10","modifiedBy":"ONEDATA","dateModified":"2021-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C46F9B82-5F01-14D5-E053-4EBD850A99AD","beginDate":"2021-06-10","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-06-10","modifiedBy":"ONEDATA","dateModified":"2021-06-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008584","version":"1","preferredName":"Disease-Disorder Classification","preferredDefinition":"the grouping of diseases and disorders into classes or categories.","longName":"DZ_DISORDER_CLASS","context":"EDRN","contextVersion":"1","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"CAAB9A16-A8FF-455E-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-10-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2003-10-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3298600","version":"1","preferredName":"Leukodystrophy Type","preferredDefinition":"A group of rare genetic neurodegenerative disorders that affect infants and children. These disorders are characterized by metabolic abnormalities in the development of the myelin sheaths in the white matter. Clinical signs and symptoms include developmental delays, mental retardation, dementia, seizures, loss of motor skills, and muscle weakness. Representative examples include metachromatic leukodystrophy, Krabbe disease, Canavan disease, and Alexander disease.:Type; a subdivision of a particular kind of thing.","longName":"C61253:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukodystrophy","conceptCode":"C61253","definition":"A group of rare genetic neurodegenerative disorders that affect infants and children. These disorders are characterized by metabolic abnormalities in the development of the myelin sheaths in the white matter. Clinical signs and symptoms include developmental delays, mental retardation, dementia, seizures, loss of motor skills, and muscle weakness. Representative examples include metachromatic leukodystrophy, Krabbe disease, Canavan disease, and Alexander disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B05C6036-0ACB-024C-E040-BB89AD43392F","latestVersionIndicator":"Yes","beginDate":"2011-10-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-10-28","modifiedBy":"ONEDATA","dateModified":"2011-10-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B05C6036-0ADC-024C-E040-BB89AD43392F","latestVersionIndicator":"Yes","beginDate":"2011-10-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-10-28","modifiedBy":"KUMMEROA","dateModified":"2021-06-25","changeDescription":". 2021-6-25 ak Released per Janet review. PV added for 2037r3. 06/09/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"lds_base_subtype","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify the leukodystrophy subtype:","type":"Alternate Question Text","description":"Specify the leukodystrophy subtype:","url":null,"context":"NHLBI"},{"name":"What is the leukodystrophy cl","type":"Preferred Question Text","description":"What is the leukodystrophy classification type?","url":null,"context":"NHLBI"},{"name":"Leukodystrophy subtype:","type":"Alternate Question Text","description":"Leukodystrophy subtype:","url":null,"context":"NHLBI"},{"name":"For which type of leukodystrophy was the infusion performed?","type":"Alternate Question Text","description":"For which type of leukodystrophy was the infusion performed?","url":null,"context":"NHLBI"},{"name":"Specify the leukodystrophy subtype","type":"Application Standard Question Text","description":"Specify the leukodystrophy subtype","url":null,"context":"NHLBI"},{"name":"Specify the leukodystrophy subtype","type":"Alternate Question Text","description":"Specify the leukodystrophy subtype","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B05C6036-0B2F-024C-E040-BB89AD43392F","latestVersionIndicator":"Yes","beginDate":"2011-10-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-10-28","modifiedBy":"KUMMEROA","dateModified":"2021-06-25","changeDescription":". 2021-6-25 ak Released per Janet review. 2021-3-19 ak System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}